Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarcosine and Benzoate for Schizophrenia
NCT01047592Phase 2Completed
- Sponsor
- Ministry of Health and Welfare Changhua Hospital
- Start
- Mar 2009
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sarcosine, sodium benzoate in schizophrenia, sponsored by Ministry of Health and Welfare Changhua Hospital. Started Mar 2009; status: completed.
02
Drugs
sarcosinesodium benzoate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01047592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01047592.